Dr. Brian Nahed is a Neurosurgeon at the Massachusetts General Hospital / Harvard Medical School specializing in Brain Tumors (glioblastoma, low-grade and high-grade gliomas, meningiomas, oliogodendrogliomas, metastatic cancer to the brain). Dr. Nahed specializes in brain tumors in Brain Mapping, Neuromonitoring, and Intraoperative technology to safely operate in the language and motor centers and maximize surgical resection. Dr. Nahed is a specialist in using intraoperative MRI and ultrasound to maximize the extent of resection.
Dr. Brian Nahed serves as Associate Professor in the Department of Neurosurgery at the Massachusetts General Hospital, Harvard Medical School, and Pappas Brain Tumor Center.
As a surgeon-scientist, Dr. Brian Nahed leads a translational research program which aims to develop the first blood based tests to diagnose and monitor patients with brain tumors. Together with Dr. Shannon Stott, they published the first evidence of circulating tumor cells in the blood of patients with gliomas. Their current NIH funded research project focuses on developing a liquid biopsy for brain tumors in adults and pediatric patients. They are currently enrolling patients into the study.
Dr. Brian Nahed is the Associate Program Director of the MGH Neurosurgery Residency. He specializes in teaching advanced neurosurgical techniques on intra-operative mapping in the resection of brain tumors.
Dr Nahed serves on the Executive Committee for the Congress of Neurological Surgeons and Co-chairs the CNS Leadership Institute focused on leadership training for neurosurgeons nationally and internationally. He serves on the executive committee of the AANS/CNS Joint Section on Brain Tumors and is an active member of the American Association of Neurological Surgeons (AANS).
Dr. Nahed serves as a neurotrauma consultant for the National Football League (NFL).